← Open Payments lookup

KELLY NASH: Open Payments

NPI 1568059582 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$360 in 16 payments from 12 companies in 2025. Trend: 2023 $140 · 2024 $139 · 2025 $360

Food & beverage: $360
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.4$88
AstraZeneca Pharmaceuticals LP2$49
ARGENX US, INC.1$31
ABBVIE INC.1$28
Regeneron Healthcare Solutions, Inc.1$27
Genentech USA, Inc.1$25
Celgene Corporation1$23
Eisai Inc.1$21
Janssen Biotech, Inc.1$20
JAZZ PHARMACEUTICALS INC.1$19

Products named: HYQVIA, VONVENDI, LYNPARZA, VYVGART HYTRULO, RUBRACA, ELAHERE, DUPIXENT, Itovebi.

Industry payments across TX — which companies pay providers there.